Target intelligence / Profile preview

U6 small nuclear RNA 221, pseudogene (RNU6-221P)

Target: RNU6-221P
Molecular classification: Pseudogene, Non-coding RNA-derived sequence

Overview

RNU6-221P is a pseudogene derived from the U6 small nuclear RNA gene family. Unlike functional U6 snRNA genes, pseudogenes like RNU6-221P do not produce a functional RNA product and lack a biological role in the cell. The U6 small nuclear RNA gene itself codes for an essential component of the spliceosome responsible for catalyzing the removal of introns from pre-mRNA in eukaryotes[1][3]. The presence of many U6 snRNA pseudogenes throughout the vertebrate genome reflects evolutionary events such as gene duplication and genomic rearrangement but does not confer any functional response or therapeutic targetability[3].

Other names: RNU6-221PRNA, U6 small nuclear 221, pseudogene

Mechanism of action

Not applicable

Biological functions

None (no known function; pseudogenes do not generally have biological activity). Note: The parent gene, U6 snRNA, is involved in pre-mRNA splicing as a component of the spliceosome[1][3], but the pseudogene itself is non-functional.

Disease associations

None known directly for this pseudogene. Some pseudogenes are associated with disease if they regulate gene expression or are involved in genomic instability, but there is no evidence specifically for RNU6-221P[2]. Parent U6 snRNA gene is essential for cell viability but not specifically linked to disease in the context of the pseudogene.

Beyond the preview

Go deeper on U6 small nuclear RNA 221, pseudogene (RNU6-221P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on U6 small nuclear RNA 221, pseudogene (RNU6-221P).

Explore the full profile